Cases & Deals

Odyssey Thera raises capital in Series A round

Clients Odyssey Thera, Inc.

Jones Day represented Odyssey Thera, Inc., a research and development organization specializing in targeted therapies for cancer, in its issuance of new Series A Convertible Preferred Stock in a private placement to Merck & Co., Inc., Burrill & Company, HBM Partners, and Healthcap.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.